Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nicolas Madranges"'
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(3)
Introduction Drug–drug interactions with cyclin-dependent kinases inhibitors 4 and 6 (CDK4/6) are known and should be taken into account. Case report A 68-year-old woman, on prior Simvastatin therapy, developed severe rhabdomyolysis after three wee
Autor:
Louis-Marie, Ecomard, Nathalie, Malingret, Maryam, Asad-Syed, Marie-Hélène, Dilhuydy, Nicolas, Madranges, Catherine, Payet, Marc, Debled
Publikováno v:
Bulletin du cancer. 100(7-8)
Breast cancer among older women is a major and increasing public health issue. No clear recommendation has been established in France after 74 years, the age limit for state-organised screening program. A survey was performed among all regional agenc
Publikováno v:
Journal of Oncology Pharmacy Practice; Apr2021, Vol. 27 Issue 3, p722-726, 5p
Autor:
Baffert, Sandrine1 sandrine.baffert@curie.net, Cottu, Paul2 paul.cottu@curie.net, Kirova, Youlia M.3 youlia.kirova@curie.net, Mercier, Florence4 florence.colin@statprocess.com, Simondi, Cécile5 cecile.simondi@curie.net, Bachelot, Thomas6 thomas.bachelot@lyon.unicancer.fr, Le Rhun, Emilie7,8 E-lerhun@o-lambret.fr, Levy, Christelle9 c.levy@baclesse.unicancer.fr, Gutierrez, Maya10 maya.gutierrez@curie.net, Madranges, Nicolas11 n.madranges@bordeaux.unicancer.fr, Moldovan, Cristian12 cristian.moldovan@chb.unicancer.fr, Coudert, Bruno13 bcoudert@cgfl.fr, Spaëth, Dominique14 oncomed@wanadoo.fr, Serin, Daniel15 d.serin@isc84.org, Cotté, François-Emery16 cottefe@yahoo.fr, Benjamin, Laure16 laure.l.benjamin@gsk.com, Maillard, Cathie17 cathy2.maillard@wanadoo.fr, Laulhere-Vigneau, Sabine17 slaulhere@cerimedical.com, Durand-Zaleski, Isabelle18 isabelle.durand-zaleski@hmn.aphp.fr
Publikováno v:
BMC Health Services Research. 2013, Vol. 13 Issue 1, p1-20. 21p. 3 Charts, 2 Graphs.
Autor:
Pons-Tostivint, Elvire, Kirova, Youlia, Lusque, Amélie, Campone, Mario, Geffrelot, Julien, Mazouni, Chafika, Mailliez, Audrey, Pasquier, David, Madranges, Nicolas, Firmin, Nelly, Crouzet, Agathe, Gonçalves, Anthony, Jankowski, Clémentine, De La Motte Rouge, Thibault, Pouget, Nicolas, de La Lande, Brigitte, Mouttet-Boizat, Delphine, Ferrero, Jean-Marc, Uwer, Lionel, Eymard, Jean-Christophe
Publikováno v:
Annals of Surgical Oncology: An Oncology Journal for Surgeons; Feb2019, Vol. 26 Issue 2, p356-365, 10p
Autor:
Debled, Marc, Madranges, Nicolas, Trainaud, Alexandra, Floquet, Anne, Donamaria, Catherine, Brouste, Véronique, Durand, Michel, Mauriac, Louis
Publikováno v:
Oncology; 2009, Vol. 77 Issue 5, p318-327, 10p, 1 Diagram, 4 Charts, 4 Graphs
Autor:
Camille Chakiba, Laurent Mignot, Hervé Bonnefoi, N. Madranges, Paul Cottu, Dorothee Chocteau-Bouju, Jean-Yves Pierga, N Quenel-Tueux, Philippe Beuzeboc, Véronique Diéras, Marc Debled
Publikováno v:
Cancer Research. 75:P5-19
Background: The on line publication in December 2011 of the Bolero-2 study (Baselga et al, NEJM) establishing the added value of everolimus (Eve) in endocrine resistant breast cancer (BC) patients (pts) has triggered its immediate use in current prac